Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication-Reference-Cited by-同舟云学术

Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication

Published:2024-07-19 Issue: Volume: Page:
ISSN:2008-2231
Container-title:DARU Journal of Pharmaceutical Sciences
language:en
Short-container-title:DARU J Pharm Sci

Author:

Das Swarnali^ORCID,Nath Sreyashi^ORCID,Shahjahan ^ORCID,Dey Sanjay Kumar^ORCID

Funder

Institute of Eminence, University of Delhi

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40199-024-00524-z.pdf

Reference206 articles.

1. Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, et al. A new threat from an old enemy: Re-emergence of coronavirus (Review). Int J Mol Med. 2020;45(6):1631–43.

2. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan, ST . COVID-19: A global challenge with old history, epidemiology and progress so far. Molecules. 2021;26:39. https://doi.org/10.3390/molecules26010039. Accessed 25 Mar 2024

3. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544. https://doi.org/10.1038/s41564-020-0695-z. Accessed 25 Mar 2024.

4. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls. Treasure Island (FL): Stat Pearls Publishing Copyright © 2021, StatPearls Publishing LLC.; 2021.

5. Efrati S, Catalogna M, Abu Hamed R, Hadanny A, Bar-Chaim A, Benveniste-Levkovitz P, et al. Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients. Sci Rep. 2021;11(1):13780.